Product Patents
Upsher-Smith owns several brand and generic products that are protected by patents in the United States. Additional patents may be pending. This page is intended to provide notice under 35 U.S.C. § 287 (a).
Klor‐Con® M
(Potassium Chloride Extended-Release Tablets)
US 6,780,437
Qudexy® XR
(topiramate) Extended-Release Capsules
US 8,652,527
US 8,889,190
US 9,101,545
US 9,555,005
US 10,172,878
US 10,363,224
Testosterone Gel, CIII
US 8,785,426
US 9,295,675
US 9,662,340
Topiramate Extended-Release Capsules
US 8,652,527
US 8,889,190
US 9,101,545
US 9,555,005
US 10,172,878
US 10,363,224
Tosymra®
(sumatriptan) Nasal Spray
US 8,268,791
US 8,440,631
US 9,211,282
US 9,283,280
US 9,610,280
US 9,974,770
US 10,603,305
Vogelxo®
(testosterone) gel, CIII
US 8,785,426
US 9,295,675
US 9,662,340
Zembrace® SymTouch®
(sumatriptan injection)
US 10,537,554